Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

New Tech Deployed for COVID-19 Testing to Toronto's FIFA World Cup

Stockhouse Editorial
9 Comments| September 2, 2021

{{labelSign}}  Favorites
{{errorMessage}}


(Image via Relay Medical Inc.)

A Canadian technology innovator focused on the development of novel technologies in the diagnostics and AI data science sectors is providing rapid COVID-19 testing and real-time tracking at Canada’s 2022 FIFA World Cup Qatar qualifying matches in Toronto.

Relay Medical Corp. (CSE: RELA), through its joint venture company, Fionet Rapid Response Group, has teamed up with LifeLabs LP to deliver remote rapid COVID-19 testing and tracking with Fio Corporation’s Fionet platform.

Relay Medical’s Chief Medical Officer, Yoav Raiter said in a news release on Thursday, “Soccer is a powerful international sport that sees fans and participants from all over the world."

The Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Combining a fast, handheld point-of-need device connected in real time to cloud data services, the Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing, data integration with other testing devices, result notification, public health notification as appropriate, and anonymized data and stats for dashboards for authorized stakeholders.

Relay Medical recently reported a successful deployment of its Fionet Platform at the 2021 National Bank Open Tennis tournament.

LifeLabs deployed the Fionet platform for testing athletes, officials, tournament employees, and other attending personnel at the tournament.

Testing began at the Toronto site on July 31st and continued for the duration of the tournament. During the tournament, LifeLabs and the Fionet system completed over 2,000 antigen tests, with an average test result time of 15 minutes.

The company added that Fionet can be deployed into almost any location, processing at least 60 tests an hour; a solution previously available only in centralized lab facilities. Through an alliance with LifeLabs, it is integrated into LifeLabs' laboratory information system as a turnkey, end-to-end COVID-19 rapid diagnostic testing program for testing and real-time tracking of COVID-19 at remote and decentralized locations.



{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today